Aureobasidins A to R were isolated from the fermentation broth of Aureobasidium pullulans R106. Aureobasidins are cyclic depsipeptide antibiotics with MW's ranging from 1,070 to 1,148. Aureobasidins showed high in vitro antifungal activity against Candida albicans.
In the course of our screening for antifungal substances from various microorganisms, newantifungal antibiotics that we namedaureobasidins wereobtained from the fermentation broth of a strain of Aureobasidium pullulans, a species of black yeast.1>2) The producing organism, strain R106, was isolated from a leaf collected at Tsushima in Nagasaki, Japan.
In this paper we describe the taxonomy of the producing organism, the production and isolation procedures of aureobasidins A to R, and their physico-chemical and biological properties. The structural studies of aureobasidins A to R will be described in the following papers.3A)
Materials and Methods
General FAB-MSwere recorded on a Jeol JMS DX-302 spectrometer. Optical rotations were measured with a Jasco DIP-181. The antibiotics were hydrolyzed with 6n HC1at 110°C and the hydrolysates were examined in an amino acid autoanalyzer (Jeol JCL-300).
Detection of Aureobasidins
Aureobasidins were detected by a bioassay, which was carried out by the paper disc diffusion method, based on their in vitro antifungal activity against Candida albicans TIMM0136 grown in a medium consisting of yeast nitrogen base (Difco) 0.67% and glucose 2%.
Aureobasidin A concentrations were measured by reversed phase HPLC(Capcell Pak C18, Shiseido) with a solvent of acetonitrile-water (7 : 3) at the UVabsorption of 230nm.
Measurement of Antifungal Activity
The MICsagainst fungi were determined by an agar dilution method on Casitone agar medium. Aureobasidins were dissolved in methanol and the solution was diluted with 50%aqueous methanol. A loopful of a fungal cell suspension in sterile water (5 x 107 cells/ml) prepared from the slant culture was streaked on the surface of the agar plates that contained a drug. After incubation of the plates at 30°C SEPT. 1991 for 3 days, the lowest concentration of the drug causing virtually complete growth inhibition was determined astheMIC.
Results

Taxonomic Studies
The cultural characteristics of strain R106on various media after incubation for 4, 7 and 14 days at 25°C are shown in Table 1 . The temperature permitting growth of the strain was 12.5 to 29°C, and optimum temperature for growth was 23 to 29°C. The strain showed good growth in a vitamin-free medium. Strain R106 showed good growth on potato -dextrose (PD) agar, Czapek agar, and yeast extract -malt extract agar media. The surface of colonies of the strain was usually mucoid or pasty, and were sometimes velvety; with time, the colonies became leathery. The color of colonies was white to creamy or light pink, then changing olive green to light brown or brown, and often finally changing to black with production of dark brown pigments, which were insoluble. Rhizoid-like structures often formed around the colonies. Hyphae sized 2 to 15/mi i.d. elongated into the agar mediumwithout forming aerial mycelia. Blastic Fermentatio n A loopful of cells of a slant culture of strain R106 was inoculated in 100ml of a liquid medium composed of yeast nitrogen base (Difco) 0.67% and glucose 2% in a 500-ml Erlenmeyer flask and the flask was shaken at 25°C for 2 days to give a seed culture. The seed culture (1,000ml) was transferred into a 200-liter fermenter containing 100 liters of a medium consisting of glucose 2%, (NH4)2SO4 0.5%, KH2PO4 0.15%, MgSO4-7H2O 0.05%, CaCl2-2H2O 0.01%, NaCl 0.01%, FeCl3-6H2O 0.5^g/ml and ZnSO4 à"7H2O 0.5 /xg/ml. Fermentation was carried out at 25°C for 56 hours with aeration (100 liters/minute) and agitation (100rpm). To the culture, 20 liters of a medium containing glucose 10%, (NH4)2SO4 2.5%, Polypepton 5%, KH2PO4 0.75%, MgSO4-7H2O 0.25%, CaCl2-2H2O 0.05%, NaCl 0.05%, FeCl3 -6H2O 2.5 /ig/ml and ZnSO4-7H2O2.5 /zg/ml was supplemented, and fermentation was further continued at 25°C for 78 hours with aeration (120 liters/minute) and agitation (100 rpm).
The time course of the production of aureobasidin A is shown in Fig. 2 . Isolation and Purification The fermentation broth was centrifuged to separate the supernatant and the mycelial cake. The mycelial cake was extracted with 10 liters of ethanol. The ethanol extract was concentrated under reduced pressure Fig. 2 . Time course of production of aureobasidin A by fermentation. O Aureobacidin A Gug/ml), à" pH, å glucose (mg/ml), A packed cell volume (ml/10ml). SEPT. 1991 to remove ethanol and the residue was extracted twice with ethyl acetate. The ethyl acetate extract was concentrated to dryness under reduced pressure, and the residue was dissolved in chloroform. The chloroform solution was put onto a column of silica gel (1.5 liters). After the column was washed with 3 liters ofhexane, it was developed and eluted with 6 liters ofhexane -2-propanol (7 : 3). The active fraction eluted with hexane-2-propanol was condensed under reduced pressure to give 15 g of a residue.
The residue was dissolved in acetonitrile. HPLC analysis of the solution suggested that at least 10 related compoundswere contained in the residue (Fig. 3) .
The solution was applied on a preparative ODS-silica gel column of Soken Pak/C18 (5cm x 50cm, 15/30^m) and developed with acetonitrilewater (7 : 3). The fractions containing aureobasidins A to R were collected separately and concentrated under reduced pressure to give residues of crude aureobasidins A to R. The residues containing A, D, E, F, G, H, I, J, P, Q and Rwere each dissolved in acetonitrile, applied on a column of Capcell Pak C18 (2x25cm) and eluted with acetonitrile-°w ater (7 : 3) to give pure aureobasidins (A: 3,500 mg, hexane -2-propanol -acetonitrile (85 : 6 : 9) to obtain purified aureobasidins (B: 55mg, and C: 54mg). The residue containing aureobasidins K, L and Mwas purified in the same way by silica gel HPLCcolumn chromatography to obtain pure aureobasidins (K: 107 mg, L: 42 mg, and M: 78 mg). The residue containing aureobasidins N and Owas also purified by silica gel HPLCto obtain pure aureobasidins (N: 18 mg, and O:18mg).
Physico-chemical Properties
Some properties of aureobasidins A to R are summarized in Table 2 . Aureobasidins showed maxima at 258 (s 3,850) and 264 nm (s 2,660) in UVabsorption spectrum in methanol. Aureobasidins were soluble in ethanol, chloroform, ethyl ether and insoluble in water. Aureobasidins contained phenylalanine, proline, and leucine in common, and contained five different amino acids, including TV-methylated amino acids. Aureobasidins were cyclic depsipeptide antibiotics containing eight amino acids and a hydroxy acid3) 4) with MW's of 1,070-1,148.
Biological Properties
The antifungal activity of aureobasidins is shown in Table 3 . Aureobasidins showed strong antifungal activity, especially against C. albicans. Aureobasidins A, B, C and E showed higher activity than the others.
Aureobasidin A, B, E or G showed no signs of toxicity when administered once to mice intraperitoneally at the dose of 200mg/kg.
Details of the biological properties of aureobasidin A, including its in vitro and in vivo antifungal activity, will be described elsewhere. SEPT. 1991 Discussion There are some peptide antibiotics with antifungal activity, including the aculeacin/echinocandin family and lipopeptin.8~12) These antibiotics all contain fatty acids, which are important for their activity. Aureobasidins are new antifungal peptide antibiotics without fatty acids, but which have high activity and low toxicity.
